1-methyl-3-isobutylxanthine has been researched along with devazepide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sandvik, AK; Waldum, HL | 1 |
Hildebrand, P; Jensen, RT; Mantey, SA; Mrozinski, JE; Patto, RJ | 1 |
Ottaway, CA | 1 |
3 other study(ies) available for 1-methyl-3-isobutylxanthine and devazepide
Article | Year |
---|---|
CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Gastric Acid; Gastric Mucosa; Gastrins; Histamine Release; In Vitro Techniques; Kinetics; Phenylurea Compounds; Rats; Receptors, Cholecystokinin; Stomach | 1991 |
Pancreatic acini possess endothelin receptors whose internalization is regulated by PLC-activating agents.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Amylases; Animals; Benzodiazepinones; Bombesin; Calcimycin; Carbachol; Cholecystokinin; Cyclic AMP; Devazepide; Endothelins; Enzyme Activation; In Vitro Techniques; Kinetics; Male; Pancreas; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Secretin; Sincalide; Tetradecanoylphorbol Acetate; Type C Phospholipases; Vasoactive Intestinal Peptide | 1993 |
Interaction of a sulfhydryl analogue of vasoactive intestinal peptide (VIP) with murine lymphocytes.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Benzodiazepinones; Cell Line; Concanavalin A; Cyclic AMP; Devazepide; Lymph Nodes; Lymphocyte Activation; Lymphocytes; Mesentery; Mice; Mice, Inbred BALB C; Mitogens; Receptors, Vasoactive Intestinal Peptide; Vasoactive Intestinal Peptide | 1995 |